peptide 1 glp 1 receptor agonist GLP-1 agonists show promise in treating substance use disorders The Impact of GLP-1 Receptor
Description
What are the implications of mediation discontinuation, contraindications, emerging long-term safety, and efficacy data
There are actually many more
To manage outcomes and costs, one in three (34%) firms now require employees to participate in lifestyle or clinical support programs before allowing clinical approval of GLP-1 agonists for weight loss
Apolipoprotein e and alzheimers disease: the influence of apolipoprotein e on amyloid-beta and other amyloidogenic proteins
Int J Biol Sci (2022) 18(5):204759
